Atossa Therapeutics
ATOS
#9237
Rank
HK$0.80 B
Marketcap
HK$6.22
Share price
5.24%
Change (1 day)
-34.44%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : HK$53.09 Million

According to Atossa Therapeutics's latest financial reports the company's total liabilities are HK$53.09 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$38.56 M-5.7%
2023-12-31HK$40.89 M-6%
2022-12-31HK$43.5 M78.48%
2021-12-31HK$24.37 M-79.94%
2020-12-31HK$0.12 B1069.45%
2019-12-31HK$10.38 M-54.5%
2018-12-31HK$22.83 M138.46%
2017-12-31HK$9.57 M17.89%
2016-12-31HK$8.12 M-58.12%
2015-12-31HK$19.38 M10.32%
2014-12-31HK$17.57 M61.04%
2013-12-31HK$10.91 M-14.7%
2012-12-31HK$12.79 M8.93%
2011-12-31HK$11.74 M74.1%
2010-12-31HK$6.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$883.85 B 1,664,694.72%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$74.33 B 139,908.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$68.66 B 129,240.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
HK$0.15 B 194.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
HK$4.17 B 7,766.42%๐Ÿ‡บ๐Ÿ‡ธ USA